29 results
P
patients
I/C
balloon, amnion, platelet-rich plasma (PRP), intrauterine device (IUD), hyaluronic acid (HA), platelet-rich fibrin (PRF), granulocyte colony-stimulating factor (G-CSF), no treatment, balloon, amnion, PRP + balloon, IUD + balloon, HA + balloon, PRF + balloon, G-CSF + balloon
O
change in AFS scores, recurrence rate of moderate-to-severe uterine adhesions, clinical pregnancy rate
P
overweight or obese patients with knee osteoarthritis
I/C
platelet-rich plasma (PRP), hyaluronic acid (HA)
O
pain and functional relief
P
patients with temporomandibular joint osteoarthritis
I/C
intra-articular injections of corticosteroids (CCS), hyaluronic acid (HA), and platelet-rich plasma (PRP), placebo injection
O
temporomandibular joint pain, maximal mouth opening (mm), lateral movement to the affected side (mm)
P
children
I/C
polyacrylate polyalcohol copolymer, Dextranomer-Hyaluronic Acid, two bulking agents
O
ureters in PPC group were more likely to undergo complete reflux resolution, UVJO incidence was higher in the PPC group
P
recreationally trained males
I/C
heat acclimation (HA), no intervention
O
physiological measures at rest (oxygen saturation), heart rate, core temperature, skin temperature, ventilation, performance measures (peak power, time trial time)
P
painful knee osteoarthritis (KOA)
I/C
intraarticular botulinum toxin type A (BTA), intraarticular corticosteroid and hyaluronic acid (HA)
O
efficacy and safety
P
patients suffering minor trauma
I/C
arthroscopic ankle microperforations, platelet-rich plasma (PRP), hyaluronic acid (HA), bone marrow concentrate (BMC), control groups
O
pain relief, return to daily activities
P
healthy subjects
I/C
acetazolamide, ibuprofen
O
efficiency in preventing acute mountain sickness
P
advanced gallbladder cancer patients
I/C
palliative chemotherapy
O
survival, adverse effects
P
adult patients with generalized anxiety disorder
I/C
vortioxetine, standard psychopharmacological treatment
O
response to treatment, anxious symptoms, nausea